This presentation covers genetic engineering technology including economic data, regulations, and security.
Advances in science and technology are changing the nature of chemical and biological warfare, in many cases making these weapons easier and cheaper to develop.
A new emerging risks report urges re/insurers to engage with the expanding synthetic biology sector to support the development of new technologies and new risk transfer solutions.
SynBioBeta 2018 is the premier industry networking event for biological engineers, entrepreneurs, innovators and investors who share a passion for engineering biology to build a better, more sustainable universe. The event showcases the synthetic biology that is transforming how we fuel, heal and feed the world. Come be a part of the bio revolution, join us at SynBioBeta: Where Tech Meets Bio, and Bio Meets Tech.
Assessing the potential GoF risks on engineered fast-growing microbes does not lead to a clear outcome that can be applied to all types of engineered fast-growing strains.
This report develops a framework to guide an assessment of the security concerns related to advances in synthetic biology, assesses the levels of concern warranted for such advances, and identifies options that could help mitigate those concerns.
A study ordered by the US Department of Defense (DoD) has concluded that new genetic-engineering tools are expanding the range of malicious uses of biology and decreasing the amount of time needed to carry them out.
Last year, researchers recreated an extinct smallpox-like virus with DNA bought online for just $100,000 and published how they did it.
At “germ games” held in Washington, DC, pandemic planners looked at the threat posed by synthetic biology.
Making use of synthetic biology requires a society-wide conversation about benefits and risks.